Details of the Drug

General Information of Drug (ID: DMZKVIE)

Drug Name

BNT151

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

mRNA (modRNA)

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04455620) Phase I/IIa, First-in-human, Open-label, Dose Escalation Trial With Expansion Cohorts to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BNT151 as a Monotherapy and in Combination With Other Anti-cancer Agents in Patients With Solid Tumors. U.S.National Institutes of Health.